anonymous
Guest
anonymous
Guest
Genentech is long dead - exists in name only. Roche and their big pharma approach to everything is the future. This means time to go if you haven’t left already. There is life after Roche and I have to tell you, it’s much better. My base pay is significantly higher, senior title, RSU’s actually worth something and bigger bonuses. The only people that will remain are the Legacy HER2 lazy CS’s and the people not smart enough to leave when they could be in contro of when and where they land.